| 1 | familial | 2,602 |
| 2 | high-grade | 1,743 |
| 3 | low-grade | 1,099 |
| 4 | hereditary | 904 |
| 5 | sporadic | 548 |
| 6 | dilating | 106 |
| 7 | polygenic | 94 |
| 8 | monogenic | 79 |
| 9 | anca-associated | 63 |
| 10 | non-carious | 50 |
| 11 | mixed-type | 42 |
| 12 | non-familial | 42 |
| 13 | non-syndromic | 31 |
| 14 | noncarious | 26 |
| 15 | endoscopy-negative | 23 |
| 16 | nonfamilial | 23 |
| 17 | hypogonadotropic | 20 |
| 18 | higher-grade | 19 |
| 19 | residual/recurrent | 18 |
| 20 | biopsy-proved | 17 |
| 21 | neuromyelitis | 15 |
| 22 | ultrafilterable | 15 |
| 23 | guideline-consistent | 14 |
| 24 | non-brca1/2 | 14 |
| 25 | hypogonadotrophic | 13 |
| 26 | nonepithelial | 13 |
| 27 | recurrent/persistent | 12 |
| 28 | subependymal | 12 |
| 29 | hyperreninemic | 11 |
| 30 | subaxial | 11 |
| 31 | ascus-favor | 10 |
| 32 | diet-resistant | 9 |
| 33 | histologically-confirmed | 9 |
| 34 | hypergonadotropic | 9 |
| 35 | lower-grade | 9 |
| 36 | noncaseating | 9 |
| 37 | significance/low-grade | 9 |
| 38 | bevacizumab-associated | 8 |
| 39 | brca1-associated | 8 |
| 40 | gly-16 | 8 |
| 41 | physician-taken | 8 |
| 42 | ppi-induced | 8 |
| 43 | unsynchronized | 8 |
| 44 | cetuximab-induced | 7 |
| 45 | cobblestone | 7 |
| 46 | heat-insoluble | 7 |
| 47 | non-hereditary | 7 |
| 48 | retrocochlear | 7 |
| 49 | acei-induced | 6 |
| 50 | biopsy-verified | 6 |
| 51 | pre-ppci | 6 |
| 52 | well-growing | 6 |
| 53 | xanthomatous | 6 |
| 54 | cyclosporine-induced | 5 |
| 55 | haart-associated | 5 |
| 56 | high-penetrance | 5 |
| 57 | hla-conferred | 5 |
| 58 | intravenous-inhalation | 5 |
| 59 | nonscreening | 5 |
| 60 | ppi-associated | 5 |
| 61 | significance-low-grade | 5 |
| 62 | split-cuff | 5 |
| 63 | tyloxapol-induced | 5 |
| 64 | anca-positive | 4 |
| 65 | arms2/htra1 | 4 |
| 66 | art-induced | 4 |
| 67 | bfysg | 4 |
| 68 | galectin-3-dependent | 4 |
| 69 | hpv-positive/atypical | 4 |
| 70 | hypergonadotrophic | 4 |
| 71 | iv-degree | 4 |
| 72 | nonserous | 4 |
| 73 | pre-bidirectional | 4 |
| 74 | rtx-induced | 4 |
| 75 | valsartan-induced | 4 |
| 76 | 17x | 3 |
| 77 | ace-inhibitor-induced | 3 |
| 78 | acei-associated | 3 |
| 79 | arabin | 3 |
| 80 | bd-induced | 3 |
| 81 | brdu-labeled | 3 |
| 82 | carbohydrate-induced | 3 |
| 83 | cis-platinum-induced | 3 |
| 84 | diabetes-promoted | 3 |
| 85 | er-ve | 3 |
| 86 | fat-adjusted | 3 |
| 87 | histology-confirmed | 3 |
| 88 | lowgrade | 3 |
| 89 | mdapanc-28 | 3 |
| 90 | nonhyperkeratotic | 3 |
| 91 | pdi® | 3 |
| 92 | stage-iii | 3 |
| 93 | triton-induced | 3 |
| 94 | xlear | 3 |
| 95 | y265c | 3 |
| 96 | ≥atypical | 3 |
| 97 | 3508 | 2 |
| 98 | ace-i-induced | 2 |
| 99 | acridocarpus-al | 2 |
| 100 | cd106+ | 2 |
| 101 | colesional | 2 |
| 102 | control-period | 2 |
| 103 | ct1an0m0 | 2 |
| 104 | esomeprazole/low-dose | 2 |
| 105 | gln-treated | 2 |
| 106 | haart-induced | 2 |
| 107 | hpv-16-related | 2 |
| 108 | hypercholesterolaemias | 2 |
| 109 | hypermagnesiuric | 2 |
| 110 | isomir | 2 |
| 111 | kardiol | 2 |
| 112 | laboratory-supported | 2 |
| 113 | lhi-induced | 2 |
| 114 | magnesuric | 2 |
| 115 | minor-grade | 2 |
| 116 | non-testicular | 2 |
| 117 | noncorrigible | 2 |
| 118 | nonresolved | 2 |
| 119 | osteoporosis/ | 2 |
| 120 | pre-superior | 2 |
| 121 | prostatic-origin | 2 |
| 122 | proteinuria-associated | 2 |
| 123 | sclerodermoid | 2 |
| 124 | serous-type | 2 |
| 125 | trace-to-mild | 2 |
| 126 | us-detected | 2 |
| 127 | vinblastine-treated | 2 |
| 128 | white-yellow | 2 |
| 129 | 'ruptured | 1 |
| 130 | -cyclometalated | 1 |
| 131 | -negative/atypical | 1 |
| 132 | /high-grade | 1 |
| 133 | /low-grade | 1 |
| 134 | 0-3years | 1 |
| 135 | 1-stearoyl-2 | 1 |
| 136 | 10/382 | 1 |
| 137 | 10^5 | 1 |
| 138 | 140/168 | 1 |
| 139 | 18-associated | 1 |
| 140 | 2.3mg | 1 |
| 141 | 20,920 | 1 |
| 142 | 202/385 | 1 |
| 143 | 21,164 | 1 |
| 144 | 22:74-88 | 1 |
| 145 | 23298 | 1 |
| 146 | 3,3'-biscoumarin | 1 |
| 147 | 3rd-degree | 1 |
| 148 | 504,093 | 1 |
| 149 | 52,440 | 1 |
| 150 | 9,471 | 1 |
| 151 | 99mtc-human | 1 |
| 152 | 9:1071-1078 | 1 |
| 153 | actinomyces-positive | 1 |
| 154 | adults.we | 1 |
| 155 | aerobic/micro-aerobic | 1 |
| 156 | aldo-salt | 1 |
| 157 | alzheimer's-related | 1 |
| 158 | another-agent-based | 1 |
| 159 | antidepressants.quetiapine | 1 |
| 160 | aptime | 1 |
| 161 | aquify | 1 |
| 162 | axillary-approached | 1 |
| 163 | batiste | 1 |
| 164 | bel/fu | 1 |
| 165 | belzer | 1 |
| 166 | brca1/2-negative | 1 |
| 167 | casein-induced | 1 |
| 168 | chaihu-jia-longgu-muli | 1 |
| 169 | chemokine-associated | 1 |
| 170 | chitosan/chitooligomer/glucosamine | 1 |
| 171 | chronified | 1 |
| 172 | cirrhosis-induced | 1 |
| 173 | colposcopically-guided | 1 |
| 174 | colposcopy-confirmed | 1 |
| 175 | controllong | 1 |
| 176 | delayed/blocked | 1 |
| 177 | detectable/undetectable | 1 |
| 178 | dietotherapy-resistant | 1 |
| 179 | difficult-to-detect | 1 |
| 180 | diuresis-induced | 1 |
| 181 | div1 | 1 |
| 182 | education/exercise | 1 |
| 183 | electrostimulator-guided | 1 |
| 184 | endometrial-specific | 1 |
| 185 | esential | 1 |
| 186 | famlial | 1 |
| 187 | fluticason | 1 |
| 188 | forearc | 1 |
| 189 | form-familiar | 1 |
| 190 | fx-evoked | 1 |
| 191 | g6pg/hereditary | 1 |
| 192 | gerlach | 1 |
| 193 | glyco-conjugate | 1 |
| 194 | gonococcal/chlamydial | 1 |
| 195 | haemorrhagic-to-necrotic | 1 |
| 196 | hemoglogin | 1 |
| 197 | hepatitis-c-virus-induced | 1 |
| 198 | highly-branched | 1 |
| 199 | histology-proved | 1 |
| 200 | hpv16/18-negative-associated | 1 |
| 201 | hsil/invasive | 1 |
| 202 | hypereninemic | 1 |
| 203 | hyperkinemic | 1 |
| 204 | igf-1-expressing | 1 |
| 205 | illness.the | 1 |
| 206 | kerukup | 1 |
| 207 | leuprolide-induced | 1 |
| 208 | levofloxa- | 1 |
| 209 | lta-accelerated | 1 |
| 210 | m121i | 1 |
| 211 | malabsorption-induced | 1 |
| 212 | mdck- | 1 |
| 213 | me180 | 1 |
| 214 | metastatic/unresectable | 1 |
| 215 | methionine-labelled | 1 |
| 216 | microsample | 1 |
| 217 | mild-grade | 1 |
| 218 | mir-193a-transfected | 1 |
| 219 | moderate-grade | 1 |
| 220 | ms-5 | 1 |
| 221 | mts-induced | 1 |
| 222 | nilotinib-induced | 1 |
| 223 | non-brca1/brca2-associated | 1 |
| 224 | non-chromatin-bound | 1 |
| 225 | non-hpv16-positive | 1 |
| 226 | nongerminomatous | 1 |
| 227 | nonseminomas/mixed | 1 |
| 228 | normal/atypical | 1 |
| 229 | operable/operated | 1 |
| 230 | papaniclaou | 1 |
| 231 | peridotitic | 1 |
| 232 | platin-induced | 1 |
| 233 | platinum-exposed | 1 |
| 234 | poligenic | 1 |
| 235 | postransplantational | 1 |
| 236 | pr/dis | 1 |
| 237 | pre-iti | 1 |
| 238 | pregravidic | 1 |
| 239 | preorthodontic | 1 |
| 240 | primoridial | 1 |
| 241 | psychosine-induced | 1 |
| 242 | pva-coated | 1 |
| 243 | radiologist-assessed | 1 |
| 244 | resch | 1 |
| 245 | retrotranscription | 1 |
| 246 | schedule-induced | 1 |
| 247 | scimed | 1 |
| 248 | scleral/episcleral | 1 |
| 249 | sex/gender-based | 1 |
| 250 | sixty-6 | 1 |
| 251 | subcentimetre | 1 |
| 252 | t2-4a | 1 |
| 253 | ta-impregnated | 1 |
| 254 | th2-driven | 1 |
| 255 | thin-grade | 1 |
| 256 | ticagrelor-associated | 1 |
| 257 | tissue‑specific | 1 |
| 258 | type-iia | 1 |
| 259 | ugs-associated | 1 |
| 260 | ultra-incompressible | 1 |
| 261 | variable-flow | 1 |
| 262 | vertebral-artery-type | 1 |
| 263 | ygk-treated | 1 |
| 264 | α-secretase-derived | 1 |
| 1 | 'ruptured | 1 |
| 2 | -cyclometalated | 1 |
| 3 | -negative/atypical | 1 |
| 4 | /high-grade | 1 |
| 5 | /low-grade | 1 |
| 6 | 0-3years | 1 |
| 7 | 1-stearoyl-2 | 1 |
| 8 | 10/382 | 1 |
| 9 | 10^5 | 1 |
| 10 | 140/168 | 1 |
| 11 | 17x | 3 |
| 12 | 18-associated | 1 |
| 13 | 2.3mg | 1 |
| 14 | 20,920 | 1 |
| 15 | 202/385 | 1 |
| 16 | 21,164 | 1 |
| 17 | 22:74-88 | 1 |
| 18 | 23298 | 1 |
| 19 | 3,3'-biscoumarin | 1 |
| 20 | 3508 | 2 |
| 21 | 3rd-degree | 1 |
| 22 | 504,093 | 1 |
| 23 | 52,440 | 1 |
| 24 | 9,471 | 1 |
| 25 | 99mtc-human | 1 |
| 26 | 9:1071-1078 | 1 |
| 27 | ace-i-induced | 2 |
| 28 | ace-inhibitor-induced | 3 |
| 29 | acei-associated | 3 |
| 30 | acei-induced | 6 |
| 31 | acridocarpus-al | 2 |
| 32 | actinomyces-positive | 1 |
| 33 | adults.we | 1 |
| 34 | aerobic/micro-aerobic | 1 |
| 35 | aldo-salt | 1 |
| 36 | alzheimer's-related | 1 |
| 37 | anca-associated | 63 |
| 38 | anca-positive | 4 |
| 39 | another-agent-based | 1 |
| 40 | antidepressants.quetiapine | 1 |
| 41 | aptime | 1 |
| 42 | aquify | 1 |
| 43 | arabin | 3 |
| 44 | arms2/htra1 | 4 |
| 45 | art-induced | 4 |
| 46 | ascus-favor | 10 |
| 47 | axillary-approached | 1 |
| 48 | batiste | 1 |
| 49 | bd-induced | 3 |
| 50 | bel/fu | 1 |
| 51 | belzer | 1 |
| 52 | bevacizumab-associated | 8 |
| 53 | bfysg | 4 |
| 54 | biopsy-proved | 17 |
| 55 | biopsy-verified | 6 |
| 56 | brca1-associated | 8 |
| 57 | brca1/2-negative | 1 |
| 58 | brdu-labeled | 3 |
| 59 | carbohydrate-induced | 3 |
| 60 | casein-induced | 1 |
| 61 | cd106+ | 2 |
| 62 | cetuximab-induced | 7 |
| 63 | chaihu-jia-longgu-muli | 1 |
| 64 | chemokine-associated | 1 |
| 65 | chitosan/chitooligomer/glucosamine | 1 |
| 66 | chronified | 1 |
| 67 | cirrhosis-induced | 1 |
| 68 | cis-platinum-induced | 3 |
| 69 | cobblestone | 7 |
| 70 | colesional | 2 |
| 71 | colposcopically-guided | 1 |
| 72 | colposcopy-confirmed | 1 |
| 73 | control-period | 2 |
| 74 | controllong | 1 |
| 75 | ct1an0m0 | 2 |
| 76 | cyclosporine-induced | 5 |
| 77 | delayed/blocked | 1 |
| 78 | detectable/undetectable | 1 |
| 79 | diabetes-promoted | 3 |
| 80 | diet-resistant | 9 |
| 81 | dietotherapy-resistant | 1 |
| 82 | difficult-to-detect | 1 |
| 83 | dilating | 106 |
| 84 | diuresis-induced | 1 |
| 85 | div1 | 1 |
| 86 | education/exercise | 1 |
| 87 | electrostimulator-guided | 1 |
| 88 | endometrial-specific | 1 |
| 89 | endoscopy-negative | 23 |
| 90 | er-ve | 3 |
| 91 | esential | 1 |
| 92 | esomeprazole/low-dose | 2 |
| 93 | familial | 2,602 |
| 94 | famlial | 1 |
| 95 | fat-adjusted | 3 |
| 96 | fluticason | 1 |
| 97 | forearc | 1 |
| 98 | form-familiar | 1 |
| 99 | fx-evoked | 1 |
| 100 | g6pg/hereditary | 1 |
| 101 | galectin-3-dependent | 4 |
| 102 | gerlach | 1 |
| 103 | gln-treated | 2 |
| 104 | gly-16 | 8 |
| 105 | glyco-conjugate | 1 |
| 106 | gonococcal/chlamydial | 1 |
| 107 | guideline-consistent | 14 |
| 108 | haart-associated | 5 |
| 109 | haart-induced | 2 |
| 110 | haemorrhagic-to-necrotic | 1 |
| 111 | heat-insoluble | 7 |
| 112 | hemoglogin | 1 |
| 113 | hepatitis-c-virus-induced | 1 |
| 114 | hereditary | 904 |
| 115 | high-grade | 1,743 |
| 116 | high-penetrance | 5 |
| 117 | higher-grade | 19 |
| 118 | highly-branched | 1 |
| 119 | histologically-confirmed | 9 |
| 120 | histology-confirmed | 3 |
| 121 | histology-proved | 1 |
| 122 | hla-conferred | 5 |
| 123 | hpv-16-related | 2 |
| 124 | hpv-positive/atypical | 4 |
| 125 | hpv16/18-negative-associated | 1 |
| 126 | hsil/invasive | 1 |
| 127 | hypercholesterolaemias | 2 |
| 128 | hypereninemic | 1 |
| 129 | hypergonadotrophic | 4 |
| 130 | hypergonadotropic | 9 |
| 131 | hyperkinemic | 1 |
| 132 | hypermagnesiuric | 2 |
| 133 | hyperreninemic | 11 |
| 134 | hypogonadotrophic | 13 |
| 135 | hypogonadotropic | 20 |
| 136 | igf-1-expressing | 1 |
| 137 | illness.the | 1 |
| 138 | intravenous-inhalation | 5 |
| 139 | isomir | 2 |
| 140 | iv-degree | 4 |
| 141 | kardiol | 2 |
| 142 | kerukup | 1 |
| 143 | laboratory-supported | 2 |
| 144 | leuprolide-induced | 1 |
| 145 | levofloxa- | 1 |
| 146 | lhi-induced | 2 |
| 147 | low-grade | 1,099 |
| 148 | lower-grade | 9 |
| 149 | lowgrade | 3 |
| 150 | lta-accelerated | 1 |
| 151 | m121i | 1 |
| 152 | magnesuric | 2 |
| 153 | malabsorption-induced | 1 |
| 154 | mdapanc-28 | 3 |
| 155 | mdck- | 1 |
| 156 | me180 | 1 |
| 157 | metastatic/unresectable | 1 |
| 158 | methionine-labelled | 1 |
| 159 | microsample | 1 |
| 160 | mild-grade | 1 |
| 161 | minor-grade | 2 |
| 162 | mir-193a-transfected | 1 |
| 163 | mixed-type | 42 |
| 164 | moderate-grade | 1 |
| 165 | monogenic | 79 |
| 166 | ms-5 | 1 |
| 167 | mts-induced | 1 |
| 168 | neuromyelitis | 15 |
| 169 | nilotinib-induced | 1 |
| 170 | non-brca1/2 | 14 |
| 171 | non-brca1/brca2-associated | 1 |
| 172 | non-carious | 50 |
| 173 | non-chromatin-bound | 1 |
| 174 | non-familial | 42 |
| 175 | non-hereditary | 7 |
| 176 | non-hpv16-positive | 1 |
| 177 | non-syndromic | 31 |
| 178 | non-testicular | 2 |
| 179 | noncarious | 26 |
| 180 | noncaseating | 9 |
| 181 | noncorrigible | 2 |
| 182 | nonepithelial | 13 |
| 183 | nonfamilial | 23 |
| 184 | nongerminomatous | 1 |
| 185 | nonhyperkeratotic | 3 |
| 186 | nonresolved | 2 |
| 187 | nonscreening | 5 |
| 188 | nonseminomas/mixed | 1 |
| 189 | nonserous | 4 |
| 190 | normal/atypical | 1 |
| 191 | operable/operated | 1 |
| 192 | osteoporosis/ | 2 |
| 193 | papaniclaou | 1 |
| 194 | pdi® | 3 |
| 195 | peridotitic | 1 |
| 196 | physician-taken | 8 |
| 197 | platin-induced | 1 |
| 198 | platinum-exposed | 1 |
| 199 | poligenic | 1 |
| 200 | polygenic | 94 |
| 201 | postransplantational | 1 |
| 202 | ppi-associated | 5 |
| 203 | ppi-induced | 8 |
| 204 | pr/dis | 1 |
| 205 | pre-bidirectional | 4 |
| 206 | pre-iti | 1 |
| 207 | pre-ppci | 6 |
| 208 | pre-superior | 2 |
| 209 | pregravidic | 1 |
| 210 | preorthodontic | 1 |
| 211 | primoridial | 1 |
| 212 | prostatic-origin | 2 |
| 213 | proteinuria-associated | 2 |
| 214 | psychosine-induced | 1 |
| 215 | pva-coated | 1 |
| 216 | radiologist-assessed | 1 |
| 217 | recurrent/persistent | 12 |
| 218 | resch | 1 |
| 219 | residual/recurrent | 18 |
| 220 | retrocochlear | 7 |
| 221 | retrotranscription | 1 |
| 222 | rtx-induced | 4 |
| 223 | schedule-induced | 1 |
| 224 | scimed | 1 |
| 225 | scleral/episcleral | 1 |
| 226 | sclerodermoid | 2 |
| 227 | serous-type | 2 |
| 228 | sex/gender-based | 1 |
| 229 | significance-low-grade | 5 |
| 230 | significance/low-grade | 9 |
| 231 | sixty-6 | 1 |
| 232 | split-cuff | 5 |
| 233 | sporadic | 548 |
| 234 | stage-iii | 3 |
| 235 | subaxial | 11 |
| 236 | subcentimetre | 1 |
| 237 | subependymal | 12 |
| 238 | t2-4a | 1 |
| 239 | ta-impregnated | 1 |
| 240 | th2-driven | 1 |
| 241 | thin-grade | 1 |
| 242 | ticagrelor-associated | 1 |
| 243 | tissue‑specific | 1 |
| 244 | trace-to-mild | 2 |
| 245 | triton-induced | 3 |
| 246 | tyloxapol-induced | 5 |
| 247 | type-iia | 1 |
| 248 | ugs-associated | 1 |
| 249 | ultra-incompressible | 1 |
| 250 | ultrafilterable | 15 |
| 251 | unsynchronized | 8 |
| 252 | us-detected | 2 |
| 253 | valsartan-induced | 4 |
| 254 | variable-flow | 1 |
| 255 | vertebral-artery-type | 1 |
| 256 | vinblastine-treated | 2 |
| 257 | well-growing | 6 |
| 258 | white-yellow | 2 |
| 259 | xanthomatous | 6 |
| 260 | xlear | 3 |
| 261 | y265c | 3 |
| 262 | ygk-treated | 1 |
| 263 | α-secretase-derived | 1 |
| 264 | ≥atypical | 3 |
| 1 | cd106+ | 2 |
| 2 | levofloxa- | 1 |
| 3 | mdck- | 1 |
| 4 | osteoporosis/ | 2 |
| 5 | 20,920 | 1 |
| 6 | 52,440 | 1 |
| 7 | me180 | 1 |
| 8 | ct1an0m0 | 2 |
| 9 | 9,471 | 1 |
| 10 | arms2/htra1 | 4 |
| 11 | div1 | 1 |
| 12 | 1-stearoyl-2 | 1 |
| 13 | non-brca1/2 | 14 |
| 14 | 10/382 | 1 |
| 15 | 504,093 | 1 |
| 16 | 21,164 | 1 |
| 17 | ms-5 | 1 |
| 18 | 202/385 | 1 |
| 19 | 10^5 | 1 |
| 20 | sixty-6 | 1 |
| 21 | gly-16 | 8 |
| 22 | 3508 | 2 |
| 23 | mdapanc-28 | 3 |
| 24 | 140/168 | 1 |
| 25 | 9:1071-1078 | 1 |
| 26 | 22:74-88 | 1 |
| 27 | 23298 | 1 |
| 28 | t2-4a | 1 |
| 29 | type-iia | 1 |
| 30 | y265c | 3 |
| 31 | aerobic/micro-aerobic | 1 |
| 32 | sporadic | 548 |
| 33 | pregravidic | 1 |
| 34 | endometrial-specific | 1 |
| 35 | tissue‑specific | 1 |
| 36 | hypogonadotrophic | 13 |
| 37 | hypergonadotrophic | 4 |
| 38 | hyperkinemic | 1 |
| 39 | hypereninemic | 1 |
| 40 | hyperreninemic | 11 |
| 41 | non-syndromic | 31 |
| 42 | poligenic | 1 |
| 43 | monogenic | 79 |
| 44 | polygenic | 94 |
| 45 | hypogonadotropic | 20 |
| 46 | hypergonadotropic | 9 |
| 47 | hypermagnesiuric | 2 |
| 48 | magnesuric | 2 |
| 49 | peridotitic | 1 |
| 50 | preorthodontic | 1 |
| 51 | haemorrhagic-to-necrotic | 1 |
| 52 | nonhyperkeratotic | 3 |
| 53 | forearc | 1 |
| 54 | cetuximab-induced | 7 |
| 55 | nilotinib-induced | 1 |
| 56 | bd-induced | 3 |
| 57 | leuprolide-induced | 1 |
| 58 | schedule-induced | 1 |
| 59 | cyclosporine-induced | 5 |
| 60 | psychosine-induced | 1 |
| 61 | carbohydrate-induced | 3 |
| 62 | ace-i-induced | 2 |
| 63 | acei-induced | 6 |
| 64 | lhi-induced | 2 |
| 65 | ppi-induced | 8 |
| 66 | tyloxapol-induced | 5 |
| 67 | cis-platinum-induced | 3 |
| 68 | valsartan-induced | 4 |
| 69 | casein-induced | 1 |
| 70 | platin-induced | 1 |
| 71 | malabsorption-induced | 1 |
| 72 | triton-induced | 3 |
| 73 | ace-inhibitor-induced | 3 |
| 74 | diuresis-induced | 1 |
| 75 | cirrhosis-induced | 1 |
| 76 | mts-induced | 1 |
| 77 | hepatitis-c-virus-induced | 1 |
| 78 | art-induced | 4 |
| 79 | haart-induced | 2 |
| 80 | rtx-induced | 4 |
| 81 | electrostimulator-guided | 1 |
| 82 | colposcopically-guided | 1 |
| 83 | axillary-approached | 1 |
| 84 | highly-branched | 1 |
| 85 | chronified | 1 |
| 86 | biopsy-verified | 6 |
| 87 | delayed/blocked | 1 |
| 88 | fx-evoked | 1 |
| 89 | brdu-labeled | 3 |
| 90 | methionine-labelled | 1 |
| 91 | scimed | 1 |
| 92 | histology-confirmed | 3 |
| 93 | histologically-confirmed | 9 |
| 94 | colposcopy-confirmed | 1 |
| 95 | hla-conferred | 5 |
| 96 | 'ruptured | 1 |
| 97 | sex/gender-based | 1 |
| 98 | another-agent-based | 1 |
| 99 | platinum-exposed | 1 |
| 100 | radiologist-assessed | 1 |
| 101 | vinblastine-treated | 2 |
| 102 | ygk-treated | 1 |
| 103 | gln-treated | 2 |
| 104 | brca1-associated | 8 |
| 105 | non-brca1/brca2-associated | 1 |
| 106 | 18-associated | 1 |
| 107 | anca-associated | 63 |
| 108 | proteinuria-associated | 2 |
| 109 | bevacizumab-associated | 8 |
| 110 | chemokine-associated | 1 |
| 111 | hpv16/18-negative-associated | 1 |
| 112 | acei-associated | 3 |
| 113 | ppi-associated | 5 |
| 114 | ticagrelor-associated | 1 |
| 115 | ugs-associated | 1 |
| 116 | haart-associated | 5 |
| 117 | -cyclometalated | 1 |
| 118 | hpv-16-related | 2 |
| 119 | alzheimer's-related | 1 |
| 120 | ta-impregnated | 1 |
| 121 | pva-coated | 1 |
| 122 | lta-accelerated | 1 |
| 123 | operable/operated | 1 |
| 124 | mir-193a-transfected | 1 |
| 125 | us-detected | 2 |
| 126 | diabetes-promoted | 3 |
| 127 | laboratory-supported | 2 |
| 128 | fat-adjusted | 3 |
| 129 | α-secretase-derived | 1 |
| 130 | nonresolved | 2 |
| 131 | histology-proved | 1 |
| 132 | biopsy-proved | 17 |
| 133 | nonseminomas/mixed | 1 |
| 134 | unsynchronized | 8 |
| 135 | sclerodermoid | 2 |
| 136 | trace-to-mild | 2 |
| 137 | non-chromatin-bound | 1 |
| 138 | control-period | 2 |
| 139 | high-penetrance | 5 |
| 140 | mild-grade | 1 |
| 141 | moderate-grade | 1 |
| 142 | high-grade | 1,743 |
| 143 | /high-grade | 1 |
| 144 | thin-grade | 1 |
| 145 | higher-grade | 19 |
| 146 | lower-grade | 9 |
| 147 | minor-grade | 2 |
| 148 | low-grade | 1,099 |
| 149 | significance-low-grade | 5 |
| 150 | /low-grade | 1 |
| 151 | significance/low-grade | 9 |
| 152 | lowgrade | 3 |
| 153 | 3rd-degree | 1 |
| 154 | iv-degree | 4 |
| 155 | illness.the | 1 |
| 156 | ultrafilterable | 15 |
| 157 | metastatic/unresectable | 1 |
| 158 | detectable/undetectable | 1 |
| 159 | noncorrigible | 2 |
| 160 | ultra-incompressible | 1 |
| 161 | heat-insoluble | 7 |
| 162 | microsample | 1 |
| 163 | aptime | 1 |
| 164 | chitosan/chitooligomer/glucosamine | 1 |
| 165 | antidepressants.quetiapine | 1 |
| 166 | cobblestone | 7 |
| 167 | mixed-type | 42 |
| 168 | serous-type | 2 |
| 169 | vertebral-artery-type | 1 |
| 170 | subcentimetre | 1 |
| 171 | education/exercise | 1 |
| 172 | esomeprazole/low-dose | 2 |
| 173 | glyco-conjugate | 1 |
| 174 | batiste | 1 |
| 175 | er-ve | 3 |
| 176 | hsil/invasive | 1 |
| 177 | brca1/2-negative | 1 |
| 178 | endoscopy-negative | 23 |
| 179 | non-hpv16-positive | 1 |
| 180 | anca-positive | 4 |
| 181 | actinomyces-positive | 1 |
| 182 | adults.we | 1 |
| 183 | split-cuff | 5 |
| 184 | 2.3mg | 1 |
| 185 | nonscreening | 5 |
| 186 | igf-1-expressing | 1 |
| 187 | noncaseating | 9 |
| 188 | dilating | 106 |
| 189 | well-growing | 6 |
| 190 | controllong | 1 |
| 191 | bfysg | 4 |
| 192 | gerlach | 1 |
| 193 | resch | 1 |
| 194 | m121i | 1 |
| 195 | pre-ppci | 6 |
| 196 | stage-iii | 3 |
| 197 | chaihu-jia-longgu-muli | 1 |
| 198 | pre-iti | 1 |
| 199 | acridocarpus-al | 2 |
| 200 | -negative/atypical | 1 |
| 201 | hpv-positive/atypical | 4 |
| 202 | normal/atypical | 1 |
| 203 | ≥atypical | 3 |
| 204 | primoridial | 1 |
| 205 | gonococcal/chlamydial | 1 |
| 206 | nonepithelial | 13 |
| 207 | familial | 2,602 |
| 208 | non-familial | 42 |
| 209 | nonfamilial | 23 |
| 210 | famlial | 1 |
| 211 | esential | 1 |
| 212 | subaxial | 11 |
| 213 | subependymal | 12 |
| 214 | colesional | 2 |
| 215 | postransplantational | 1 |
| 216 | pre-bidirectional | 4 |
| 217 | scleral/episcleral | 1 |
| 218 | kardiol | 2 |
| 219 | 99mtc-human | 1 |
| 220 | physician-taken | 8 |
| 221 | th2-driven | 1 |
| 222 | arabin | 3 |
| 223 | prostatic-origin | 2 |
| 224 | hemoglogin | 1 |
| 225 | 3,3'-biscoumarin | 1 |
| 226 | intravenous-inhalation | 5 |
| 227 | retrotranscription | 1 |
| 228 | fluticason | 1 |
| 229 | kerukup | 1 |
| 230 | retrocochlear | 7 |
| 231 | xlear | 3 |
| 232 | form-familiar | 1 |
| 233 | non-testicular | 2 |
| 234 | belzer | 1 |
| 235 | isomir | 2 |
| 236 | pre-superior | 2 |
| 237 | ascus-favor | 10 |
| 238 | hypercholesterolaemias | 2 |
| 239 | pr/dis | 1 |
| 240 | neuromyelitis | 15 |
| 241 | 0-3years | 1 |
| 242 | non-carious | 50 |
| 243 | noncarious | 26 |
| 244 | nonserous | 4 |
| 245 | xanthomatous | 6 |
| 246 | nongerminomatous | 1 |
| 247 | difficult-to-detect | 1 |
| 248 | aldo-salt | 1 |
| 249 | diet-resistant | 9 |
| 250 | dietotherapy-resistant | 1 |
| 251 | galectin-3-dependent | 4 |
| 252 | residual/recurrent | 18 |
| 253 | guideline-consistent | 14 |
| 254 | recurrent/persistent | 12 |
| 255 | bel/fu | 1 |
| 256 | papaniclaou | 1 |
| 257 | variable-flow | 1 |
| 258 | white-yellow | 2 |
| 259 | 17x | 3 |
| 260 | aquify | 1 |
| 261 | hereditary | 904 |
| 262 | non-hereditary | 7 |
| 263 | g6pg/hereditary | 1 |
| 264 | pdi® | 3 |